Pfizer’s weight loss pill is moving forward as a once-daily version

Sweep images | Lightrocket | Getty Images

Pfizer said Thursday it will go forward with a once-a-day version of its weight-loss pill, danuglipron, after it saw “encouraging” data in an ongoing early-stage trial.

The company evaluated several formulations of the once-a-day drug and identified one with “the most beneficial profile.” Pfizer said it plans to conduct studies in the second half of the year to identify the ideal dose of the drug.

Back To Top